Skip to content

CASE STUDY 06 / 06

Febuxostat solid dispersions

Ungur et al., Journal of Pharmacy and Pharmacology 2026, 78, rgag019

27 → 134µg/mL

SOLUBILITY IN WATER UNDER THE STUDY CONDITIONS

Challenge

Solubility and dissolution behavior may remain challenging even after identifying alternative solid forms.

Scientific approach

A 2026 study examined febuxostat salts and a cocrystal alongside PEG6000-based amorphous solid dispersions, including dissolution and in vitro biological tests.

Published findings

The reported Tos1 salt increased solubility from 27 ± 2 to 100 ± 2 micrograms/mL in water; its PEG6000 dispersion reached 134 ± 2 micrograms/mL under the study conditions.

Development relevance

This research illustrates how solid-form engineering and formulation-oriented investigations may be combined; the measurements are study-specific, not a commercial performance guarantee.

Source

Ungur et al., Journal of Pharmacy and Pharmacology 2026, 78, rgag019; DOI 10.1093/jpp/rgag019.

View publication(opens in a new tab)
RELATED SERVICEPreformulation & Specialized Development

Discuss Your Challenge